Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
Cinpharm manufactures generic drugs in Cameroon. Its first products were distributed to the market in October. In the medium term, the company also plans to export to its neighbouring countries in UDEAC, the Economic Community of Central African States.
In principle, generic pharma production could supply developing countries with all the drugs they need. In practice, matters are more difficult. Zafrullah Chowdhury shed light on this complex matter in an interview with Hans Dembowski.
Multinational pharma producers are based in rich nations and demand high prices, thus hampering supply of medicine to the developing world. Globally enforced patents serve to protect high prices. At the same time, few new medicines are being developed for the health problems that mostly affect poor countries. Today, even …
David Henry discusses a research article by Geoffrey Spurling and colleagues that examined the relationship between exposure to promotional material from pharmaceutical companies and the quality, quantity, and cost of prescribing. Original Source
The Drug Controller General of India (DCGI) has proposed to the Health Ministry to ban Rosiglitazone, an anti-diabetes drug widely used in India for correcting blood sugar levels. Earlier this month, DCGI Surinder Singh had directed state drug controllers to suspend all licenses for sale and distribution of Rosiglitazone. Following …
India is, today, the fourth largest producer of drugs in the world and a world class supplier of relatively cheap generic medicines. It is the largest supplier in the world of low-priced anti-retrovirals and exports medicines to over 200 countries. However, major concerns regarding access to medi cines in the …
THE government plans to make it mandatory for drugmakers to register their brands to plug a loophole that allows separate pharmaceutical companies to make and sell medicines used to treat different diseases under the same brand name.
In its first significant move towards bringing about more transparency, the Health Ministry has decided to set up a company, with independent directors on board, to procure drugs and equipment to be distributed to state-run medicare centres. The ministry itself will maintain an arm
Sudhir Chowdhary, BV Mahalakshmi : * Clinical trials using Gardasil and Cervarix Human Papilloma Virus (HPV) vaccines are abruptly stopped by the government in April this year after the deaths of six tribal girls in Andhra Pradesh and Gujarat * An infant in Bangalore, who had a pre-existing cardiac disorder, …
BRITISH drugmaker Glaxo-SmithKline (GSK) will increase its capacity to make a medicine for treatment of elephantiasis at its manufacturing facility in Nasik (India) besides its South African plant, a top company executive said. GSK makes albendazole, a medicine used by 120 million people across the world, at its production units …
New York: Pfizer Inc has agreed to buy King Pharmaceuticals Inc for $3.6 billion in a move to shore up earnings ahead of the looming evaporation of revenue from Lipitor, its biggest product. Pfizer, which is still digesting last year
INDIA will not withdraw its case against the European Union at the World Trade Organisation for wrongful seizure of drug consignments belonging to Indian companies until the regional grouping agrees to amend its Customs laws to prevent such action in future, commerce secretary Rahul Khullar said. Commerce and industry minister …
NEW DELHI: Sales growth of diabetes medicines has accelerated the fastest among all drugs sold in the country as pharma companies pushed their products to tap over 50 million people suffering from the lifestyle disease in India, making it the single largest home for diabetics in the world. Oral anti-diabetes …
